Want to see JP:5187 full AI Analyst Report?
Top Page
Create Medic Co., Ltd.
(5187)
Select Model
Select Model
Rating:70Outperform
Price Target:
¥1,254.00
▲(20.93% Upside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by solid financial stability from a low-leverage balance sheet and steady revenue growth, partially offset by uneven profitability and inconsistent cash generation (including a sharp cash flow decline in 2025). Technicals are supportive with price holding above key moving averages and positive MACD, and valuation is helped by a moderate P/E and a strong dividend yield.
Positive Factors
Conservative balance sheet
Low leverage and growing equity provide durable financial flexibility: the company can fund working capital, absorb demand shocks, and invest in incremental capacity or product development without heavy reliance on volatile external financing. That structural strength supports resilience over the next 2–6 months.
Negative Factors
Inconsistent cash generation
Sharp swing to weaker operating and free cash flow increases execution risk: it constrains funding for capex, working capital, and dividends, and may force reliance on external financing or asset sales. Persistent cash volatility undermines the company’s ability to consistently fund growth or absorb shocks over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage and growing equity provide durable financial flexibility: the company can fund working capital, absorb demand shocks, and invest in incremental capacity or product development without heavy reliance on volatile external financing. That structural strength supports resilience over the next 2–6 months.
Read all positive factors
Create Medic Co., Ltd. (5187) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥10.45B
Dividend Yield4.18%
Average Volume (3M)7.98K
Price to Earnings (P/E)14.7
Beta (1Y)0.29
Revenue Growth3.67%
EPS Growth-30.85%
CountryJP
Employees1,010
SectorHealthcare
Sector Strength45
IndustryMedical - Specialties
Share Statistics
EPS (TTM)78.19
Shares Outstanding9,664,327
10 Day Avg. Volume3,800
30 Day Avg. Volume7,980
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.53
Price to Sales (P/S)0.64
P/FCF Ratio88.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Create Medic Co., Ltd. Business Overview & Revenue Model
Company Description
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman,...
How the Company Makes Money
Create Medic primarily makes money by selling medical devices and single-use medical consumables to healthcare providers (e.g., hospitals and clinics) through domestic and export distribution channels. Its core revenue comes from recurring demand ...
Create Medic Co., Ltd. Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
83
Very Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.76B | 13.62B | 13.03B | 12.59B | 12.33B | 11.70B |
| Gross Profit | 5.96B | 5.99B | 5.70B | 5.48B | 5.37B | 5.26B |
| EBITDA | 1.48B | 1.64B | 1.73B | 1.50B | 1.47B | 1.43B |
| Net Income | 657.97M | 713.73M | 840.90M | 154.02M | 482.21M | 660.41M |
Balance Sheet | ||||||
| Total Assets | 19.92B | 20.14B | 20.05B | 19.26B | 19.12B | 18.08B |
| Cash, Cash Equivalents and Short-Term Investments | 5.43B | 5.83B | 6.32B | 4.39B | 4.31B | 4.36B |
| Total Debt | 749.70M | 749.70M | 891.96M | 884.78M | 933.42M | 815.36M |
| Total Liabilities | 3.66B | 3.81B | 4.30B | 4.31B | 4.40B | 3.86B |
| Stockholders Equity | 16.26B | 16.33B | 15.75B | 14.94B | 14.72B | 14.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 98.51M | 1.77B | 246.98M | 101.75M | 629.58M |
| Operating Cash Flow | 0.00 | 530.12M | 2.25B | 698.84M | 461.34M | 1.25B |
| Investing Cash Flow | 0.00 | -573.08M | 270.62M | -363.61M | 38.01M | -585.01M |
| Financing Cash Flow | 0.00 | -600.39M | -877.65M | -362.19M | -355.59M | -442.52M |
Create Medic Co., Ltd. Technical Analysis
Negative
1037.00
Price Trends
1106.48
Positive
1124.72
Negative
1080.05
Positive
Market Momentum
4.53
Positive
41.42
Neutral
33.54
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5187, the sentiment is Negative. The current price of 1037 is below the 20-day moving average (MA) of 1143.40, below the 50-day MA of 1106.48, and below the 200-day MA of 1080.05, indicating a neutral trend. The MACD of 4.53 indicates Positive momentum. The RSI at 41.42 is Neutral, neither overbought nor oversold. The STOCH value of 33.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5187.
Create Medic Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥17.10B | 12.92 | ― | 3.02% | 13.43% | 7.14% | |
70 Outperform | ¥10.45B | 14.69 | ― | 3.52% | 3.67% | -30.85% | |
63 Neutral | ¥260.75B | 17.82 | ― | 1.92% | 4.29% | 3.92% | |
58 Neutral | ¥140.05B | 285.71 | 0.33% | 3.73% | 0.78% | -95.37% | |
57 Neutral | ¥70.91B | 19.95 | ― | 2.28% | 2.94% | 57.05% | |
54 Neutral | ¥22.70B | -102.99 | ― | 3.12% | -6.64% | 67.08% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:5187
Create Medic Co., Ltd.
1,113.00
165.84
17.51%
JP:6523
PHC Holdings Corp.
1,311.00
365.34
38.63%
JP:4549
Eiken Chemical Co., Ltd.
2,216.00
-52.25
-2.30%
JP:6678
Techno Medica Co., Ltd.
2,116.00
235.90
12.55%
JP:6849
Nihon Kohden Corporation
1,434.50
-246.64
-14.67%
JP:7600
Japan Medical Dynamic Marketing, Inc.
920.00
391.97
74.23%
Create Medic Co., Ltd. Corporate Events
Create Medic’s First-Half Profit Slides as Margins Tighten but Dividend Rises
Aug 5, 2026
Create Medic reported consolidated net sales of ¥6,932 million for the six months ended June 30, 2026, up 5.6% year on year, but operating profit fell 38.6% to ¥336 million and profit attributable to owners of parent dropped 37.0% to ...
Create Medic Posts Higher Sales but Lower Q1 Profit, Affirms 2026 Outlook and Dividend Hike
May 7, 2026
Create Medic Co., Ltd. reported consolidated net sales of ¥3,364 million for the three months ended March 31, 2026, a 4.5% year-on-year increase, while operating profit fell 36.6% to ¥140 million and profit attributable to owners of pare...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.